MariMed CEO Jon Levine At Benzinga Cannabis Capital Conference Says Not A Time To Be Borrowing Money At High Interest Rates Unless Its Prudent To Create Cash Flow Quicker, We Want To Build This Company With Positive Cash Flow And Positive Earnings
Portfolio Pulse from Benzinga Newsdesk
MariMed CEO Jon Levine spoke at the Benzinga Cannabis Capital Conference, stating that it's not a good time to borrow money at high interest rates unless it's prudent to create cash flow quicker. He emphasized the company's focus on building with positive cash flow and earnings.
September 27, 2023 | 4:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MariMed's CEO Jon Levine's comments indicate a cautious approach to borrowing, focusing on positive cash flow and earnings. This could reassure investors about the company's financial stability.
Jon Levine's comments suggest a prudent financial strategy for MariMed, focusing on positive cash flow and earnings rather than high-interest borrowing. This could reassure investors about the company's financial stability and potentially boost the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
While MSOS is not directly mentioned in the article, the ETF includes cannabis-related stocks and could be indirectly affected by news from the sector.
MSOS, an ETF that includes cannabis-related stocks, could be indirectly affected by news from the sector. However, as it was not directly mentioned in the article, the impact is likely to be minimal.
CONFIDENCE 70
IMPORTANCE 30
RELEVANCE 20